Free Trial

Cyclo Therapeutics (CYTH) Institutional Ownership

Cyclo Therapeutics logo
$0.72 0.00 (0.00%)
As of 03/26/2025

Institutional Ownership Changes (13F Filings) for Cyclo Therapeutics (NASDAQ:CYTH)

Current
Institutional Ownership
Percentage
68.55%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$25.10K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$75.90K
Get CYTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CYTH Institutional Buying and Selling by Quarter

Remove Ads

Cyclo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2025Two Sigma Securities LLC42,541$25K0.0%N/A0.148%
2/7/2025EPIQ Capital Group LLC689,447$407K0.1%-6.8%2.396%
8/10/2024EPIQ Capital Group LLC817,270$1.04M0.4%-4.3%2.856%
2/15/2024Founders Fund V Management LLC480,708$764K80.8%N/A2.115%
2/15/2024Founders Fund VI Management LLC110,023$175K1.4%N/A0.484%
11/9/2021BlackRock Inc.13,134$88K0.0%+21.1%0.204%
8/16/2021State Street Corp44,700$457K0.0%N/A0.703%
8/13/2021Geode Capital Management LLC42,577$435K0.0%+133.2%0.670%
8/13/2021Vanguard Group Inc.151,540$1.55M0.0%+350.4%2.383%
5/12/2021Geode Capital Management LLC18,257$149K0.0%N/A0.287%
3/26/2021Susquehanna International Group LLP15,656$68K0.0%N/A0.249%
2/17/2021Jane Street Group LLC27,892$121K0.0%N/A1.641%
(Data available from 1/1/2016 forward)

Remove Ads

CYTH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CYTH shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cyclo Therapeutics shares: Founders Fund V Management LLC ($764K), EPIQ Capital Group LLC ($407K), and Founders Fund VI Management LLC ($175K), Two Sigma Securities LLC ($25K).Learn more on CYTH's institutional investors.

What percentage of Cyclo Therapeutics stock is owned by institutional investors?

68.55% of Cyclo Therapeutics stock is owned by institutional investors. Learn more on CYTH's institutional investor holdings.

Which institutional investors have been buying Cyclo Therapeutics stock?

The following institutional investors have purchased Cyclo Therapeutics stock in the last 24 months: Founders Fund V Management LLC ($480.71K), Founders Fund VI Management LLC ($110.02K), and Two Sigma Securities LLC ($42.54K).

How much institutional buying is happening at Cyclo Therapeutics?

Institutional investors have bought a total of 633,272 shares in the last 24 months. This purchase volume represents approximately $964.36K in transactions.

Which Cyclo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Cyclo Therapeutics stock in the last 24 months: EPIQ Capital Group LLC ($86.52K).

How much institutional selling is happening at Cyclo Therapeutics?

Institutional investors have sold a total of 86,524 shares in the last 24 months. This volume of shares sold represents approximately $75.90K in transactions.



This page (NASDAQ:CYTH) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners